Stock Markets September 14, 2026 03:20 PM

Comparing Broadcom, Oracle and Micron After an AI Sector Selloff

Three AI-infrastructure heavyweights fall in tandem - how their valuations, balance sheets and growth profiles stack up for dip buyers

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
AVGO ORCL MU

A coordinated selloff hit Broadcom, Oracle and Micron simultaneously, producing steep intraday drops and creating a moment to reassess each company’s risk-reward. Broadcom offers a high-quality free cash flow story and an AI “tollbooth” profile; Oracle shows the biggest implied upside but carries heavy leverage and negative levered cash flow; Micron is the most deeply discounted on earnings multiple but remains exposed to memory cyclicality.

Comparing Broadcom, Oracle and Micron After an AI Sector Selloff
AVGO ORCL MU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Sector-wide selloff affected AI infrastructure names AVGO, ORCL, MU
  • AVGO shows strongest FCF trajectory and analyst conviction; ORCL has largest upside but high leverage; MU is cheapest on forward P/E with cyclicality

Markets turned cautious across a trio of AI-infrastructure names on Sep 14 at 3:18 PM EDT, with Broadcom (AVGO) down -4.53% to $345.60, Oracle (ORCL) off -4.54% to $143.45, and Micron (MU) slipping -4.91% to $927.37. The moves are not isolated to a single company - they reflect a sector-wide re-rating that tests common dip-buying assumptions.


Snapshot comparison

Metric Broadcom (AVGO) Oracle (ORCL) Micron (MU)
Today’s Move -4.53% -4.54% -4.91%
Off 52W High -30.1% -56.4% -26.1%
Fair Value Upside 33.0% 38.8% 31.4%
Analyst Target Upside 47.8% 59.7% 57.9%
Analyst Conviction 1.26 (Str. Buy) 1.60 1.35
Fwd P/E 30.0x 18.5x 13.1x
Revenue CAGR (5Y) 21.7% 10.7% 11.8%
Debt/Equity 59.6% 273.6% 6.3%
Health Score Great Good Excellent

Values are screener snapshots and may lag live quotes.


Broadcom - the persistent cash engine

Broadcom presents itself as a structurally oriented AI play rather than a pure cyclical exposure. The company supplies custom AI accelerators to hyperscalers and builds the networking silicon that connects large-scale AI deployments - effectively capturing two distinct streams of AI spending in one business. The free cash flow track record underpins that positioning: FCF compounded from $13.3B to $26.9B over four years. Gross margin remained robust at 77.3% in FY2025. Those figures support a forward P/E near 30x, suggesting the market prices in growth without overheating.

The downside risks are explicit: customer concentration is material, with a small number of hyperscalers responsible for a large share of AI-related revenue. Sentiment also carries an episodic overhang after the June “plateau scare,” when CEO Hock Tan declined to raise the $100B AI revenue target - a communications moment that precipitated a sector-wide pullback. That dynamic means positive sentiment reversals are tied closely to clear, earnings-driven catalysts.


Oracle - biggest declared upside, heaviest leverage

Oracle shows the largest drawdown from its highs - down 56.4% - yet also the highest fair value upside at 38.8%. That combination frames Oracle as a high risk-reward candidate. The balance sheet, however, is strained: debt/equity sits at 273.6% and levered free cash flow swung to -$23.7B in FY2026, reflecting aggressive cloud infrastructure investment. At the same time, net income margin has widened to 25.4% as cloud revenue scales and the forward P/E of 18.5x looks cheap relative to a traditional enterprise software franchise.

The bullish thesis for Oracle rests on monetizing cloud backlog - if contracted cloud revenues flow through to the income statement, levered FCF could normalize quickly. The bearish counterpoint is straightforward: the company is carrying heavy leverage into a rising-rate backdrop while revenue growth is still in a ramp phase. Analysts point to material upside - 59.7% on average for price targets - but their conviction score of 1.60 trails Broadcom’s, indicating less certainty in those projections.


Micron - the lowest multiple, the cyclical wildcard

Micron stands out on valuation: a 13.1x forward P/E, roughly half Broadcom’s multiple and substantially below Oracle’s. The company is effectively unlevered, with debt/equity at 6.3% - an uncommon position for a capital-intensive memory maker. Micron’s margin history highlights cyclicality: gross margin plunged to 2.7% during the FY2023 downturn before recovering to 39.8% in FY2025. The structural pivot is the HBM4 certification on NVIDIA’s Vera Rubin platform, which provides a durable demand anchor tied to AI workloads rather than purely cyclical enterprise buying.

Several analyst upgrades clustered around June earnings, with price targets noted at RBC $1,200, Aletheia $1,600, and Wolfe $1,250, each citing DRAM pricing continuing an upcycle - the report references DRAM pricing in its 12th upcycle quarter. The countervailing risk is the speed at which memory markets can reverse; with the stock up 241.9% year-to-date, any macro shock could disproportionately affect a crowded long position.


Verdict for dip buyers

Applying a dip-buying checklist across the three names yields differentiated conclusions:

  • Best candidate for sentiment reversion: Broadcom. The company combines a clean FCF trajectory, a dual exposure to accelerators and networking silicon, and the strongest analyst conviction at 1.26. The recent dip appears tied to a communication nuance rather than a direct operational shortfall, which leaves room for a pronounced sentiment rebound if upcoming earnings provide clarity.
  • Best pure value play: Micron. The 13.1x forward P/E, minimal leverage, and HBM4 certification make it the cheapest direct link to AI infrastructure among the three. That said, the position requires careful sizing because memory markets are inherently volatile.
  • Highest risk/reward profile: Oracle. The 38.8% fair value upside and 59.7% analyst target upside are meaningful, but the elevated leverage and negative levered FCF mean this is a longer-term thesis rather than a short-term trade.

Investors weighing these names should match position sizing to the company-specific risk profile - concentrated customer exposure at Broadcom, balance-sheet leverage at Oracle, and cyclical memory risk at Micron - and treat the current sector re-rating as an earnings-dependent environment for sentiment shifts.


Key points

  • A coordinated selloff pushed AVGO, ORCL and MU lower on Sep 14, highlighting a sector-wide re-rating rather than company-specific failures.
  • Broadcom has strong free cash flow growth and high gross margins, Oracle has the largest implied upside but heavy leverage, and Micron offers the lowest forward P/E with significant cyclicality.
  • Sectors most affected include AI infrastructure, cloud services and the memory semiconductor market.

Risks and uncertainties

  • Concentrated customer exposure for Broadcom - a handful of hyperscalers drive a large portion of AI revenue, creating sensitivity to those relationships.
  • Oracle is carrying substantial debt and had levered free cash flow of -$23.7B in FY2026, which increases vulnerability to rising rates and requires successful cloud backlog monetization.
  • Micron faces typical memory-market volatility - margins have swung widely (2.7% in FY2023 to 39.8% in FY2025), and the stock’s 241.9% YTD gain leaves it exposed to rapid reversals.

Risks

  • Concentrated hyperscaler customer risk for Broadcom impacting AI revenue
  • Oracle’s high debt/equity (273.6%) and -$23.7B levered FCF in FY2026 create balance-sheet vulnerability
  • Micron’s memory cyclicality evidenced by gross margin swing (2.7% in FY2023 to 39.8% in FY2025) and large YTD gain (241.9%) increases reversal risk

More from Stock Markets

Wells Fargo commercial banking chief Manning to retire; Biodrowski named successor Sep 14, 2026 EPA Moves to Repeal Biden-Era Power Plant Emissions Limits Sep 14, 2026 Beta Bionics Shares Tick Higher After FDA Clearance for Mint Patch Pump and Senseonics Partnership Sep 14, 2026 Beta Bionics Shares Tick Higher After FDA Clears Mint Patch Pump, Company Lowers 2026 Revenue Outlook Sep 14, 2026 Sagen MI Canada Lines Up C$300 Million Bond Offering, Likely Seven-Year Maturity Sep 14, 2026